Nilandron

Known as: Aventis Behring Brand of Nilutamide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2017
01219802017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • 2017
CLINICAL PHARMACOLOGY Mechanism of Action Prostate cancer is known to be androgen sensitive and responds to androgen ablation. In… (More)
Is this relevant?
2008
2008
We report the case of a 76-year-old man who developed fulminant hepatic failure after treatment with the antiandrogen nilutamide… (More)
  • figure 1
  • table 1
Is this relevant?
2005
2005
Die A-Gammaglobulinämie eines 7 Jahre alten Jungen wurde mit i.m. Injektionen von Gammaglobulinpräparaten behandelt. Es kamen… (More)
Is this relevant?
2004
2004
247. Herren G. Tatra, G. Breitenecker, W. Gruber und P. Placheta (Wien): Schwangerschaftsspezifisches Protein {SP-1}: klinische… (More)
Is this relevant?
Review
1999
Review
1999
Many physicians use combined androgen blockade in the form of a luteinizing hormone-releasing hormone analog or bilateral… (More)
Is this relevant?
Review
1999
Review
1999
OBJECTIVES With 184,500 new cases and 39,200 deaths anticipated in 1998, prostate cancer is second only to lung cancer in cancer… (More)
Is this relevant?
1980
1980
Serum immunoreactive trypsin (IRT) determination has been recommended as a screening test in chronic pancreatitis. Using a… (More)
Is this relevant?